Steven Daniel Daveluy, MD, FAAD, discussed how artificial intelligence (AI) can leverage extensive patient data and guide dermatologists to improve early diagnosis and treatment of rare dermatological ...

A rare and potentially fatal skin infection with nightmarish outcomes may soon have a cure. The infection starts as a seemingly harmless rash, and before a person knows it, more than 30 percent of the ...

Seasoned dermatology and immunology executive brings more than 25 years of experience advancing and launching innovative ...

Woodbury man came from Libya to Minnesota for treatment of rare skin condition, then stayed to earn his degree and become a ...

And it has paved the way for other therapeutic strategies, including the first gene therapy delivered through skin grafts, which was approved this year for a form of the condition known as recessive ...

After a poor showing of its COVID med vilobelimab in a rare skin disorder trial, German drugmaker InflaRx is going back to the drawing board. The independent data monitoring committee assessing a ...

Please provide your email address to receive an email when new articles are posted on . The researchers were tasked with helping a patient who had a novel form of recalcitrant erythroderma. Using a ...

Abeona Therapeutics has secured US Food and Drug Administration (FDA) approval for Zevaskyn (prademagene zamikeracel), a gene-corrected cell therapy designed to treat recessive dystrophic ...

SALT LAKE CITY (KTVX) — A Utah woman is sharing her story after she survived an incredibly rare and often fatal skin disorder caused by an allergic reaction to antibiotics. “I’m lucky to be alive, I’m ...

In December 2025, Palvella requested a Preliminary Breakthrough Therapy Designation Advice meeting with the FDA which is anticipated for the first quarter of 2026. The Company plans to commence a ...